Key facts
- This page summarizes Asit Parikh's Form 4 filing for Phathom Pharmaceuticals, Inc. (PHAT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jan 2023, 15:32.
Asit Parikh - 12 Jan 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)
- Reporting relationship
- Director
- Issuer ticker
- PHAT
- Reported as of
- 12 Jan 2023
- Net transaction value
- +$35,000
- SEC form
- 4
- Accepted by SEC
- 12 Jan 2023, 15:32:51 UTC
- Prior SEC filing
- 27 May 2022
- Next SEC filing
- 14 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Larry Miller, Attorney-in-Fact for Asit Parikh
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Asit Parikh filed Form 4 for Phathom Pharmaceuticals, Inc. (PHAT) on 12 Jan 2023.
Change
- Previous filing in this sequence was filed on 27 May 2022.
- Current net transaction value: +$35,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PHAT
transaction
Common Stock
Purchase
- Transaction value
- $35,000
- Shares
- +5,000
- Change %
- +40%
- Price
- $7.00
- Shares after
- 17,500
- Date
- 12 Jan 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.